Kistler-Tiffany Companies’s Core Laboratories CLB Stock Holding History

Kistler-Tiffany Companies’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-16	Closed	-$2K	–	556
2018 Q3	$2K	Hold	16	–	–	﹤0.01%	534
2018 Q2	$2K	Hold	16	–	–	﹤0.01%	523
2018 Q1	$2K	Hold	16	–	–	﹤0.01%	532
2017 Q4	$2K	Hold	16	–	–	﹤0.01%	521
2017 Q3	$2K	Hold	16	–	–	﹤0.01%	497
2017 Q2	$2K	Hold	16	–	–	﹤0.01%	467
2017 Q1	$2K	Buy	+16	New	+$1.86K	﹤0.01%	474
2016 Q2	–	Sell	-100	Closed	-$11K	–	642
2016 Q1	$11K	Hold	100	–	–	0.01%	405
2015 Q4	$11K	Hold	100	–	–	0.01%	432
2015 Q3	$10K	Hold	100	–	–	0.01%	439
2015 Q2	$11K	Hold	100	–	–	0.01%	445
2015 Q1	$10K	Hold	100	–	–	0.01%	436
2014 Q4	$12K	Sell	100 -30	-23%	-$3.94K	0.01%	415
2014 Q3	$19K	Buy	+130	New	+$20.1K	0.01%	372

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Kistler-Tiffany Companies's CLB Position: Q4 2018 in Review

Kistler-Tiffany Companies sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 16 shares — an estimated $2K sold.

Kistler-Tiffany Companies first reported a position in CLB in Q3 2014 and held it in 14 quarters. The position peaked at $19K in Q3 2014. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

Kistler-Tiffany Companies reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
Kistler-Tiffany Companies sold 16 Core Laboratories shares in Q4 2018, an estimated $2K.
Kistler-Tiffany Companies first reported a position in Core Laboratories in Q3 2014 and held it in 14 quarters.
Kistler-Tiffany Companies's Core Laboratories position peaked at $19K in Q3 2014.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2018, filed 14 Jan 2019.